Cargando…
Correction: Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients
Autores principales: | Wang, Ling-Zhi, Ramírez, Jacqueline, Yeo, Winnie, Chan, Mei-Yi Michelle, Thuya, Win-Lwin, Lau, Jie-Ying Amelia, Wan, Seow-Ching, Wong, Andrea Li-Ann, Zee, Ying-Kiat, Lim, Robert, Lee, Soo-Chin, Ho, Paul C., Lee, How-Sung, Chan, Anthony, Ansher, Sherry, Ratain, Mark J., Goh, Boon-Cher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890364/ http://dx.doi.org/10.1371/annotation/df796504-a2ea-4807-a412-85985bb2550b |
Ejemplares similares
-
Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients
por: Wang, Ling-Zhi, et al.
Publicado: (2013) -
Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1
por: Wang, Lingzhi, et al.
Publicado: (2017) -
Validation of a Rapid and Sensitive LC-MS/MS Method for Determination of Exemestane and Its Metabolites, 17β-Hydroxyexemestane and 17β-Hydroxyexemestane-17-O-β-D-Glucuronide: Application to Human Pharmacokinetics Study
por: Wang, Ling-Zhi, et al.
Publicado: (2015) -
Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?
por: Sundararaghavan, Vikram L., et al.
Publicado: (2016) -
Regioselective Glucuronidation of Diosmetin and Chrysoeriol by the Interplay of Glucuronidation and Transport in UGT1A9-Overexpressing HeLa Cells
por: Zeng, Xuejun, et al.
Publicado: (2016)